|
Ribavirin and Interferon alfa-2b, recombinant
|
|
Rebetron (containing a combination of ribavirin and interferon alfa-2b)
|
Ribavirin and Interferon alfa-2b, recomb... Clinical Trials
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- Triple Therapy with Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous HCV Non Responders
ClinicalTrials.gov Identifier: NCT00122629 - Terminated
Hepatitis C, Chronic
- Zidovudine Levels in HIV Infected Patients Being Treated for HCV
ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
HIV Infections; Hepatitis C
- PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
ClinicalTrials.gov Identifier: NCT00215865 - Completed
Chronic Hepatitis C Virus Infection
- Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN alfa-2b), and Ribavirin (RBV) Treatment in Patients with Hepatitis C and HIV Coinfection
ClinicalTrials.gov Identifier: NCT00015652 - Completed
HIV Infections; Hepatitis C
- Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
ClinicalTrials.gov Identifier: NCT00117533 - Recruiting
Chronic Hepatitis B; Chronic Hepatitis D
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
unspecified adult solid tumor, protocol specific
- PEG-Interferon alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00045279 - Active, not recruiting
Stage IV Renal Cell Cancer
- Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
Hepatitis C, Chronic; Fibrosis
- Temozolomide plus PEG-Interferon alfa-2B in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00014261 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
ClinicalTrials.gov Identifier: NCT00489385 - Recruiting
HIV Infections; HCV
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
ClinicalTrials.gov Identifier: NCT00134030 - Recruiting
localized osteosarcoma; metastatic osteosarcoma
- PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
Stage IV Renal Cell Cancer
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov Identifier: NCT00049530 - Recruiting
Recurrent Melanoma; Stage IV Melanoma
- A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000694 - Completed
Sarcoma, Kaposi; HIV Infections
- Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590)
ClinicalTrials.gov Identifier: NCT00378599 - Recruiting
Liver Transplantation; Hepatitis C, Chronic; Liver Cirrhosis
- Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
Hepatitis
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
stage III melanoma
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to alpha-Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039871 - Completed
Chronic Hepatitis C; Liver Fibrosis; Cirrhosis
- Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
ClinicalTrials.gov Identifier: NCT00093093 - Active, not recruiting
Chronic Hepatitis C
- Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
renal clear cell carcinoma; Stage IV Renal Cell Cancer
- An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
ClinicalTrials.gov Identifier: NCT00292084 - Active, not recruiting
Hepatitis C, Chronic
- Interferon alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
ClinicalTrials.gov Identifier: NCT00004196 - Active, not recruiting
stage I melanoma; stage II melanoma; stage III melanoma
- PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
ClinicalTrials.gov Identifier: NCT00253474 - Active, not recruiting
Neoplasm of Uncertain Malignant Potential; Unspecified Childhood Solid Tumor, Protocol Specific
- The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients with Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00001114 - Completed
Sarcoma, Kaposi; HIV Infections
- Racial Differences in HCV/Host Interactions
ClinicalTrials.gov Identifier: NCT00071916 - Recruiting
Hepatitis C
- Interferon alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov Identifier: NCT00005966 - Active, not recruiting
stage III renal cell cancer; Stage IV Renal Cell Cancer
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00238329 - Active, not recruiting
Intraocular Melanoma; Melanoma (Skin)
- Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
recurrent cervical cancer; stage IVB cervical cancer
- Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
ClinicalTrials.gov Identifier: NCT00423800 - Recruiting
Hepatitis C, Chronic
- Sunitinib Malate Alone and in Combination With Interferon Alfa as First-Line Therapy for Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00267748 - Recruiting
Renal Cell Carcinoma
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00176527 - Active, not recruiting
Prostate Cancer
- Azacitidine and Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00217542 - Recruiting
Stage III melanoma; Stage IV Melanoma; Stage IV Renal Cell Cancer; recurrent renal cell cancer; Recurrent Melanoma
- PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
ClinicalTrials.gov Identifier: NCT00052650 - Recruiting
adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain stem glioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
- Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov Identifier: NCT00192647 - Active, not recruiting
Chronic Hepatitis C
- Interferon alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
ClinicalTrials.gov Identifier: NCT00072046 - Active, not recruiting
Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00332176 - Recruiting
Chronic Hepatitis C
- Total Therapy II
ClinicalTrials.gov Identifier: NCT00083551 - Active, not recruiting
Multiple Myeloma
- Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
Hepatitis C
- Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
ClinicalTrials.gov Identifier: NCT00028093 - Recruiting
Hepatitis C
- Sodium Stibogluconate and Interferon Alfa-2b Followed By Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Advanced Melanoma or Other Cancer
ClinicalTrials.gov Identifier: NCT00498979 - Recruiting
Brain and Central Nervous System Tumors; Melanoma (Skin)
- A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
ClinicalTrials.gov Identifier: NCT00002270 - Completed
HIV Infections; Leukoencephalopathy, Progressive Multifocal
- Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00467077 - Recruiting
Kidney Cancer
- Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00471484 - Recruiting
Liver Cancer
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
HIV Infections; Hepatitis C; Liver Disease
- PEDS-C: Pegylated Interferon +/- Ribavirin for Children with Hepatitis C
ClinicalTrials.gov Identifier: NCT00100659 - Active, not recruiting
Chronic Hepatitis C
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
ClinicalTrials.gov Identifier: NCT00491179 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Long-Term Evaluation Follow-Up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former (Peg)Interferon Alfa-2b-Based Therapy
ClinicalTrials.gov Identifier: NCT00227149 - Recruiting
Hepatitis C, Chronic
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-naïve Dialysis Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00491244 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
ClinicalTrials.gov Identifier: NCT00107653 - Active, not recruiting
Hepatitis C
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
recurrent adult brain tumor
- Peginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00018031 - Recruiting
Hepatitis C; HIV Infections
- Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
stage III melanoma
- Combination Chemotherapy With or Without Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00003027 - Active, not recruiting
Stage IV Melanoma
- Efficacy and safety of Pegasys plus Copegus in patients with chronic Hepatitis C who are unable to tolerate or who do not respond to 12 weeks of therapy with PEG-Intron plus Rebetol/Ribavirin.
ClinicalTrials.gov Identifier: NCT00087568 - Completed
Hepatitis C
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus with Standard Treatment
ClinicalTrials.gov Identifier: NCT00006164 - Active, not recruiting
Chronic Hepatitis C; Cirrhosis, Liver; Fibrosis, Liver; Hepatic Cirrhosis
- Dexamethasone Plus Interferon alfa in Treating Patients With Primary Systemic Amyloidosis
ClinicalTrials.gov Identifier: NCT00002849 - Active, not recruiting
primary systemic amyloidosis
- Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00561912 - Recruiting
Renal Cell Carcinoma
- A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000725 - Completed
Sarcoma, Kaposi; HIV Infections
- Bevacizumab and PEG-Interferon alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
ClinicalTrials.gov Identifier: NCT00055809 - Completed
recurrent gastrointestinal carcinoid tumor; metastatic gastrointestinal carcinoid tumor; regional gastrointestinal carcinoid tumor
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- Interferon alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
ClinicalTrials.gov Identifier: NCT00002882 - Active, not recruiting
stage III melanoma
- Evaluation of the viral kinetics and pharmacokinetics of Pegasys plus Copegus and PEG-Intron plus Rebetol in patients with Chronic Hepatitis C and previously untreated with an interferon.
ClinicalTrials.gov Identifier: NCT00087607 - Completed
Hepatitis C
- A Phase I Trial of Peginterferon alfa-2b (PEG-Intron) for Plexiform Neurofibromas
ClinicalTrials.gov Identifier: NCT00156754 - Recruiting
- Combination Chemotherapy, Interferon alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002669 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00053820 - Active, not recruiting
Stage IV Renal Cell Cancer
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
Chronic Hepatitis C
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- Therapy with Infergen, Ribavirin, & Avandia in a Group of Insulin Resistant, Chronic Hepatitis C, Genotype 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
ClinicalTrials.gov Identifier: NCT00207402 - Not yet recruiting
Hepatitis C
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
ClinicalTrials.gov Identifier: NCT00532701 - Recruiting
Chronic Hepatitis C; Genotype 2; Peginterferon; Ribavirin
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
ClinicalTrials.gov Identifier: NCT00569127 - Not yet recruiting
Head and Neck Cancer; Islet Cell Tumor; Neuroendocrine Carcinoma of the Skin
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients with Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00196664 - Recruiting
Chronic Hepatitis C
- SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
Renal Cell Carcinoma
- Interleukin-12 and Interferon alfa in Treating Patients With Metastatic Malignant Melanoma
ClinicalTrials.gov Identifier: NCT00026143 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron™ (Trademark)) in Children with Diffuse Pontine Gliomas
ClinicalTrials.gov Identifier: NCT00036569 - Recruiting
Glioma
- Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00003656 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
Recurrent Small Cell Lung Cancer
- PEG-Interferon alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov Identifier: NCT00085384 - Suspended
recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- SU5416 and Interferon alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00006384 - Completed
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Interferon alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00027664 - Recruiting
Stage IV Renal Cell Cancer
- Oblimersen and Interferon alfa in Treating Patients With Metastatic Renal Cell Cancer
ClinicalTrials.gov Identifier: NCT00059813 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
ClinicalTrials.gov Identifier: NCT00019474 - Active, not recruiting
Pancreatic Cancer; Gastric Cancer; adult primary liver cancer
- Interferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00002847 - Active, not recruiting
Stage IV Renal Cell Cancer; recurrent renal cell cancer
- High-Dose or Low-Dose Interferon alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00002763 - Active, not recruiting
stage III melanoma; Recurrent Melanoma
- Multicenter Study Evaluating 12 Versus 24 Weeks Therapy with Peginterferon and Ribavirin for HCV Genotype 2 or 3
ClinicalTrials.gov Identifier: NCT00143000 - Recruiting
Hepatitis C Virus
- An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
ClinicalTrials.gov Identifier: NCT00000647 - Completed
HIV Infections
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
